Bacterial Vaginosis Medicine Market - Global Outlook and Forecast 2022-2028

March 2022 | 101 pages | ID: BAEC37C6CDB2EN
Market Monitor Global

Abstracts

Bacterial Vaginosis Medicine is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria.

This report contains market size and forecasts of Bacterial Vaginosis Medicine in Global, including the following market information:

Global Bacterial Vaginosis Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Bacterial Vaginosis Medicine market was valued at 943 million in 2021 and is projected to reach US$ 1145.2 million by 2028, at a CAGR of 2.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Rx Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Bacterial Vaginosis Medicine include Bayer, Pfizer, Sanofi, Piramal, Abbott, Galderma, Mission, Alkem and Xiuzheng, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bacterial Vaginosis Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bacterial Vaginosis Medicine Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Bacterial Vaginosis Medicine Market Segment Percentages, by Type, 2021 (%)

• Rx
• OTC

Global Bacterial Vaginosis Medicine Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Bacterial Vaginosis Medicine Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Pharmacy
• Other

Global Bacterial Vaginosis Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Bacterial Vaginosis Medicine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bacterial Vaginosis Medicine revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Bacterial Vaginosis Medicine revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bayer
• Pfizer
• Sanofi
• Piramal
• Abbott
• Galderma
• Mission
• Alkem
• Xiuzheng
• Teva
• Perrigo
• West-Ward
• HPGC
• Yunnan Baiyao
• Starpharma
• Novel
• Edenvridge

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Bacterial Vaginosis Medicine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Bacterial Vaginosis Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BACTERIAL VAGINOSIS MEDICINE OVERALL MARKET SIZE

2.1 Global Bacterial Vaginosis Medicine Market Size: 2021 VS 2028
2.2 Global Bacterial Vaginosis Medicine Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Bacterial Vaginosis Medicine Players in Global Market
3.2 Top Global Bacterial Vaginosis Medicine Companies Ranked by Revenue
3.3 Global Bacterial Vaginosis Medicine Revenue by Companies
3.4 Top 3 and Top 5 Bacterial Vaginosis Medicine Companies in Global Market, by Revenue in 2021
3.5 Global Companies Bacterial Vaginosis Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bacterial Vaginosis Medicine Players in Global Market
  3.6.1 List of Global Tier 1 Bacterial Vaginosis Medicine Companies
  3.6.2 List of Global Tier 2 and Tier 3 Bacterial Vaginosis Medicine Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Bacterial Vaginosis Medicine Market Size Markets, 2021 & 2028
  4.1.2 Rx
  4.1.3 OTC
4.2 By Type - Global Bacterial Vaginosis Medicine Revenue & Forecasts
  4.2.1 By Type - Global Bacterial Vaginosis Medicine Revenue, 2017-2022
  4.2.2 By Type - Global Bacterial Vaginosis Medicine Revenue, 2023-2028
  4.2.3 By Type - Global Bacterial Vaginosis Medicine Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Bacterial Vaginosis Medicine Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Pharmacy
  5.1.4 Other
5.2 By Application - Global Bacterial Vaginosis Medicine Revenue & Forecasts
  5.2.1 By Application - Global Bacterial Vaginosis Medicine Revenue, 2017-2022
  5.2.2 By Application - Global Bacterial Vaginosis Medicine Revenue, 2023-2028
  5.2.3 By Application - Global Bacterial Vaginosis Medicine Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Bacterial Vaginosis Medicine Market Size, 2021 & 2028
6.2 By Region - Global Bacterial Vaginosis Medicine Revenue & Forecasts
  6.2.1 By Region - Global Bacterial Vaginosis Medicine Revenue, 2017-2022
  6.2.2 By Region - Global Bacterial Vaginosis Medicine Revenue, 2023-2028
  6.2.3 By Region - Global Bacterial Vaginosis Medicine Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Bacterial Vaginosis Medicine Revenue, 2017-2028
  6.3.2 US Bacterial Vaginosis Medicine Market Size, 2017-2028
  6.3.3 Canada Bacterial Vaginosis Medicine Market Size, 2017-2028
  6.3.4 Mexico Bacterial Vaginosis Medicine Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Bacterial Vaginosis Medicine Revenue, 2017-2028
  6.4.2 Germany Bacterial Vaginosis Medicine Market Size, 2017-2028
  6.4.3 France Bacterial Vaginosis Medicine Market Size, 2017-2028
  6.4.4 U.K. Bacterial Vaginosis Medicine Market Size, 2017-2028
  6.4.5 Italy Bacterial Vaginosis Medicine Market Size, 2017-2028
  6.4.6 Russia Bacterial Vaginosis Medicine Market Size, 2017-2028
  6.4.7 Nordic Countries Bacterial Vaginosis Medicine Market Size, 2017-2028
  6.4.8 Benelux Bacterial Vaginosis Medicine Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Bacterial Vaginosis Medicine Revenue, 2017-2028
  6.5.2 China Bacterial Vaginosis Medicine Market Size, 2017-2028
  6.5.3 Japan Bacterial Vaginosis Medicine Market Size, 2017-2028
  6.5.4 South Korea Bacterial Vaginosis Medicine Market Size, 2017-2028
  6.5.5 Southeast Asia Bacterial Vaginosis Medicine Market Size, 2017-2028
  6.5.6 India Bacterial Vaginosis Medicine Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Bacterial Vaginosis Medicine Revenue, 2017-2028
  6.6.2 Brazil Bacterial Vaginosis Medicine Market Size, 2017-2028
  6.6.3 Argentina Bacterial Vaginosis Medicine Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Bacterial Vaginosis Medicine Revenue, 2017-2028
  6.7.2 Turkey Bacterial Vaginosis Medicine Market Size, 2017-2028
  6.7.3 Israel Bacterial Vaginosis Medicine Market Size, 2017-2028
  6.7.4 Saudi Arabia Bacterial Vaginosis Medicine Market Size, 2017-2028
  6.7.5 UAE Bacterial Vaginosis Medicine Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bayer
  7.1.1 Bayer Corporate Summary
  7.1.2 Bayer Business Overview
  7.1.3 Bayer Bacterial Vaginosis Medicine Major Product Offerings
  7.1.4 Bayer Bacterial Vaginosis Medicine Revenue in Global Market (2017-2022)
  7.1.5 Bayer Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Bacterial Vaginosis Medicine Major Product Offerings
  7.2.4 Pfizer Bacterial Vaginosis Medicine Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Sanofi
  7.3.1 Sanofi Corporate Summary
  7.3.2 Sanofi Business Overview
  7.3.3 Sanofi Bacterial Vaginosis Medicine Major Product Offerings
  7.3.4 Sanofi Bacterial Vaginosis Medicine Revenue in Global Market (2017-2022)
  7.3.5 Sanofi Key News
7.4 Piramal
  7.4.1 Piramal Corporate Summary
  7.4.2 Piramal Business Overview
  7.4.3 Piramal Bacterial Vaginosis Medicine Major Product Offerings
  7.4.4 Piramal Bacterial Vaginosis Medicine Revenue in Global Market (2017-2022)
  7.4.5 Piramal Key News
7.5 Abbott
  7.5.1 Abbott Corporate Summary
  7.5.2 Abbott Business Overview
  7.5.3 Abbott Bacterial Vaginosis Medicine Major Product Offerings
  7.5.4 Abbott Bacterial Vaginosis Medicine Revenue in Global Market (2017-2022)
  7.5.5 Abbott Key News
7.6 Galderma
  7.6.1 Galderma Corporate Summary
  7.6.2 Galderma Business Overview
  7.6.3 Galderma Bacterial Vaginosis Medicine Major Product Offerings
  7.6.4 Galderma Bacterial Vaginosis Medicine Revenue in Global Market (2017-2022)
  7.6.5 Galderma Key News
7.7 Mission
  7.7.1 Mission Corporate Summary
  7.7.2 Mission Business Overview
  7.7.3 Mission Bacterial Vaginosis Medicine Major Product Offerings
  7.7.4 Mission Bacterial Vaginosis Medicine Revenue in Global Market (2017-2022)
  7.7.5 Mission Key News
7.8 Alkem
  7.8.1 Alkem Corporate Summary
  7.8.2 Alkem Business Overview
  7.8.3 Alkem Bacterial Vaginosis Medicine Major Product Offerings
  7.8.4 Alkem Bacterial Vaginosis Medicine Revenue in Global Market (2017-2022)
  7.8.5 Alkem Key News
7.9 Xiuzheng
  7.9.1 Xiuzheng Corporate Summary
  7.9.2 Xiuzheng Business Overview
  7.9.3 Xiuzheng Bacterial Vaginosis Medicine Major Product Offerings
  7.9.4 Xiuzheng Bacterial Vaginosis Medicine Revenue in Global Market (2017-2022)
  7.9.5 Xiuzheng Key News
7.10 Teva
  7.10.1 Teva Corporate Summary
  7.10.2 Teva Business Overview
  7.10.3 Teva Bacterial Vaginosis Medicine Major Product Offerings
  7.10.4 Teva Bacterial Vaginosis Medicine Revenue in Global Market (2017-2022)
  7.10.5 Teva Key News
7.11 Perrigo
  7.11.1 Perrigo Corporate Summary
  7.11.2 Perrigo Business Overview
  7.11.3 Perrigo Bacterial Vaginosis Medicine Major Product Offerings
  7.11.4 Perrigo Bacterial Vaginosis Medicine Revenue in Global Market (2017-2022)
  7.11.5 Perrigo Key News
7.12 West-Ward
  7.12.1 West-Ward Corporate Summary
  7.12.2 West-Ward Business Overview
  7.12.3 West-Ward Bacterial Vaginosis Medicine Major Product Offerings
  7.12.4 West-Ward Bacterial Vaginosis Medicine Revenue in Global Market (2017-2022)
  7.12.5 West-Ward Key News
7.13 HPGC
  7.13.1 HPGC Corporate Summary
  7.13.2 HPGC Business Overview
  7.13.3 HPGC Bacterial Vaginosis Medicine Major Product Offerings
  7.13.4 HPGC Bacterial Vaginosis Medicine Revenue in Global Market (2017-2022)
  7.13.5 HPGC Key News
7.14 Yunnan Baiyao
  7.14.1 Yunnan Baiyao Corporate Summary
  7.14.2 Yunnan Baiyao Business Overview
  7.14.3 Yunnan Baiyao Bacterial Vaginosis Medicine Major Product Offerings
  7.14.4 Yunnan Baiyao Bacterial Vaginosis Medicine Revenue in Global Market (2017-2022)
  7.14.5 Yunnan Baiyao Key News
7.15 Starpharma
  7.15.1 Starpharma Corporate Summary
  7.15.2 Starpharma Business Overview
  7.15.3 Starpharma Bacterial Vaginosis Medicine Major Product Offerings
  7.15.4 Starpharma Bacterial Vaginosis Medicine Revenue in Global Market (2017-2022)
  7.15.5 Starpharma Key News
7.16 Novel
  7.16.1 Novel Corporate Summary
  7.16.2 Novel Business Overview
  7.16.3 Novel Bacterial Vaginosis Medicine Major Product Offerings
  7.16.4 Novel Bacterial Vaginosis Medicine Revenue in Global Market (2017-2022)
  7.16.5 Novel Key News
7.17 Edenvridge
  7.17.1 Edenvridge Corporate Summary
  7.17.2 Edenvridge Business Overview
  7.17.3 Edenvridge Bacterial Vaginosis Medicine Major Product Offerings
  7.17.4 Edenvridge Bacterial Vaginosis Medicine Revenue in Global Market (2017-2022)
  7.17.5 Edenvridge Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Bacterial Vaginosis Medicine Market Opportunities & Trends in Global Market
Table 2. Bacterial Vaginosis Medicine Market Drivers in Global Market
Table 3. Bacterial Vaginosis Medicine Market Restraints in Global Market
Table 4. Key Players of Bacterial Vaginosis Medicine in Global Market
Table 5. Top Bacterial Vaginosis Medicine Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Bacterial Vaginosis Medicine Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Bacterial Vaginosis Medicine Revenue Share by Companies, 2017-2022
Table 8. Global Companies Bacterial Vaginosis Medicine Product Type
Table 9. List of Global Tier 1 Bacterial Vaginosis Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bacterial Vaginosis Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Bacterial Vaginosis Medicine Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Bacterial Vaginosis Medicine Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Bacterial Vaginosis Medicine Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Bacterial Vaginosis Medicine Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Bacterial Vaginosis Medicine Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Bacterial Vaginosis Medicine Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2023-2028
Table 30. Bayer Corporate Summary
Table 31. Bayer Bacterial Vaginosis Medicine Product Offerings
Table 32. Bayer Bacterial Vaginosis Medicine Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Bacterial Vaginosis Medicine Product Offerings
Table 35. Pfizer Bacterial Vaginosis Medicine Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Bacterial Vaginosis Medicine Product Offerings
Table 38. Sanofi Bacterial Vaginosis Medicine Revenue (US$, Mn), (2017-2022)
Table 39. Piramal Corporate Summary
Table 40. Piramal Bacterial Vaginosis Medicine Product Offerings
Table 41. Piramal Bacterial Vaginosis Medicine Revenue (US$, Mn), (2017-2022)
Table 42. Abbott Corporate Summary
Table 43. Abbott Bacterial Vaginosis Medicine Product Offerings
Table 44. Abbott Bacterial Vaginosis Medicine Revenue (US$, Mn), (2017-2022)
Table 45. Galderma Corporate Summary
Table 46. Galderma Bacterial Vaginosis Medicine Product Offerings
Table 47. Galderma Bacterial Vaginosis Medicine Revenue (US$, Mn), (2017-2022)
Table 48. Mission Corporate Summary
Table 49. Mission Bacterial Vaginosis Medicine Product Offerings
Table 50. Mission Bacterial Vaginosis Medicine Revenue (US$, Mn), (2017-2022)
Table 51. Alkem Corporate Summary
Table 52. Alkem Bacterial Vaginosis Medicine Product Offerings
Table 53. Alkem Bacterial Vaginosis Medicine Revenue (US$, Mn), (2017-2022)
Table 54. Xiuzheng Corporate Summary
Table 55. Xiuzheng Bacterial Vaginosis Medicine Product Offerings
Table 56. Xiuzheng Bacterial Vaginosis Medicine Revenue (US$, Mn), (2017-2022)
Table 57. Teva Corporate Summary
Table 58. Teva Bacterial Vaginosis Medicine Product Offerings
Table 59. Teva Bacterial Vaginosis Medicine Revenue (US$, Mn), (2017-2022)
Table 60. Perrigo Corporate Summary
Table 61. Perrigo Bacterial Vaginosis Medicine Product Offerings
Table 62. Perrigo Bacterial Vaginosis Medicine Revenue (US$, Mn), (2017-2022)
Table 63. West-Ward Corporate Summary
Table 64. West-Ward Bacterial Vaginosis Medicine Product Offerings
Table 65. West-Ward Bacterial Vaginosis Medicine Revenue (US$, Mn), (2017-2022)
Table 66. HPGC Corporate Summary
Table 67. HPGC Bacterial Vaginosis Medicine Product Offerings
Table 68. HPGC Bacterial Vaginosis Medicine Revenue (US$, Mn), (2017-2022)
Table 69. Yunnan Baiyao Corporate Summary
Table 70. Yunnan Baiyao Bacterial Vaginosis Medicine Product Offerings
Table 71. Yunnan Baiyao Bacterial Vaginosis Medicine Revenue (US$, Mn), (2017-2022)
Table 72. Starpharma Corporate Summary
Table 73. Starpharma Bacterial Vaginosis Medicine Product Offerings
Table 74. Starpharma Bacterial Vaginosis Medicine Revenue (US$, Mn), (2017-2022)
Table 75. Novel Corporate Summary
Table 76. Novel Bacterial Vaginosis Medicine Product Offerings
Table 77. Novel Bacterial Vaginosis Medicine Revenue (US$, Mn), (2017-2022)
Table 78. Edenvridge Corporate Summary
Table 79. Edenvridge Bacterial Vaginosis Medicine Product Offerings
Table 80. Edenvridge Bacterial Vaginosis Medicine Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Bacterial Vaginosis Medicine Segment by Type in 2021
Figure 2. Bacterial Vaginosis Medicine Segment by Application in 2021
Figure 3. Global Bacterial Vaginosis Medicine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Bacterial Vaginosis Medicine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bacterial Vaginosis Medicine Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bacterial Vaginosis Medicine Revenue in 2021
Figure 8. By Type - Global Bacterial Vaginosis Medicine Revenue Market Share, 2017-2028
Figure 9. By Application - Global Bacterial Vaginosis Medicine Revenue Market Share, 2017-2028
Figure 10. By Region - Global Bacterial Vaginosis Medicine Revenue Market Share, 2017-2028
Figure 11. By Country - North America Bacterial Vaginosis Medicine Revenue Market Share, 2017-2028
Figure 12. US Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Bacterial Vaginosis Medicine Revenue Market Share, 2017-2028
Figure 16. Germany Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 17. France Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Bacterial Vaginosis Medicine Revenue Market Share, 2017-2028
Figure 24. China Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 28. India Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Bacterial Vaginosis Medicine Revenue Market Share, 2017-2028
Figure 30. Brazil Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Bacterial Vaginosis Medicine Revenue Market Share, 2017-2028
Figure 33. Turkey Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Bacterial Vaginosis Medicine Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer Bacterial Vaginosis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Bacterial Vaginosis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Bacterial Vaginosis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Piramal Bacterial Vaginosis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abbott Bacterial Vaginosis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Galderma Bacterial Vaginosis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Mission Bacterial Vaginosis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Alkem Bacterial Vaginosis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Xiuzheng Bacterial Vaginosis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Teva Bacterial Vaginosis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Perrigo Bacterial Vaginosis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. West-Ward Bacterial Vaginosis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. HPGC Bacterial Vaginosis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Yunnan Baiyao Bacterial Vaginosis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Starpharma Bacterial Vaginosis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Novel Bacterial Vaginosis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Edenvridge Bacterial Vaginosis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)